key: cord-0758423-uucxtete
authors: Vöhringer, Harald S.; Sanderson, Theo; Sinnott, Matthew; De Maio, Nicola; Nguyen, Thuy; Goater, Richard; Schwach, Frank; Harrison, Ian; Hellewell, Joel; Ariani, Cristina V.; Gonçalves, Sonia; Jackson, David K.; Johnston, Ian; Jung, Alexander W.; Saint, Callum; Sillitoe, John; Suciu, Maria; Goldman, Nick; Panovska-Griffiths, Jasmina; Birney, Ewan; Volz, Erik; Funk, Sebastian; Kwiatkowski, Dominic; Chand, Meera; Martincorena, Inigo; Barrett, Jeffrey C.; Gerstung, Moritz
title: Genomic reconstruction of the SARS-CoV-2 epidemic in England
date: 2021-10-14
journal: Nature
DOI: 10.1038/s41586-021-04069-y
sha: 6a89fd1fc704b8f26b823b923a75a68f9449ad26
doc_id: 758423
cord_uid: uucxtete

The evolution of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus leads to new variants that warrant timely epidemiological characterization. Here we use the dense genomic surveillance data generated by the COVID-19 Genomics UK Consortium to reconstruct the dynamics of 71 different lineages in each of 315 English local authorities between September 2020 and June 2021. This analysis reveals a series of subepidemics that peaked in early autumn 2020, followed by a jump in transmissibility of the B.1.1.7/Alpha lineage. The Alpha variant grew when other lineages declined during the second national lockdown and regionally tiered restrictions between November and December 2020. A third more stringent national lockdown suppressed the Alpha variant and eliminated nearly all other lineages in early 2021. Yet a series of variants (most of which contained the spike E484K mutation) defied these trends and persisted at moderately increasing proportions. However, by accounting for sustained introductions, we found that the transmissibility of these variants is unlikely to have exceeded the transmissibility of the Alpha variant. Finally, B.1.617.2/Delta was repeatedly introduced in England and grew rapidly in early summer 2021, constituting approximately 98% of sampled SARS-CoV-2 genomes on 26 June 2021.

ranging from 5% in winter 2020 to 38% in early summer 2021, and filtered to remove cases that were associated with international travel (Methods and Extended Data Fig. 1a, b) . Overall, a total of 328 SARS-CoV-2 lineages were identified using the PANGO lineage definition 5 . As some of these lineages were only rarely and intermittently detected, we collapsed these on the basis of the underlying phylogenetic tree into a set of 71 lineages for modelling (Fig. 1b-d  and Supplementary Tables 1 and 2) .

These data reveal a diversity of lineages in the fall of 2020 followed by sweeps of the Alpha and Delta variants ( Fig. 1b and Supplementary  Tables 2 and 3 ). Figure 1c shows the geographical distribution of cases and of different lineages, studied at the level of 315 English lower tier local authorities (LTLAs), administrative regions with approximately 100,000-200,000 inhabitants.

We developed a Bayesian statistical model that tracks the fraction of genomes from different lineages in each LTLA in each week and fits the daily total number of positive Pillar 2 tests (Methods and Extended Data Fig. 2 ). The multivariate logistic regression model is conceptually similar to previous approaches in its estimation of relative growth rates 10, 11 . It accounts for differences in the epidemiological dynamics between LTLAs, and enables the introduction of new lineages (Fig. 2a-c) . Despite the sampling noise in a given week, the fitted proportions recapitulate the observed proportions of genomes as revealed by 35 example LTLAs covering the geography of England (Fig. 2b , c and Supplementary Notes 1 and 2). The quality of fit is confirmed by different probabilistic model selection criteria (Extended Data Fig. 3 ) and also evident at the aggregated regional level (Extended Data Fig. 4) .

Although the relative growth rate of each lineage is modelled as identical across LTLAs, the local viral proportions change dynamically due to the timing and rate of introduction of different lineages. The model also calculates total and lineage-specific local incidences and time-dependent growth rates and approximate reproduction numbers R t by negative binomial spline fitting of the number of daily positive PCR tests (Methods, Fig. 2d and Extended Data Fig. 2c ). Together, this enables a quantitative reconstruction of different periods of the epidemic, which we will discuss in chronological order. 

Autumn 2020 was characterized by a surge of cases-concentrated in the north of England-that peaked in November, triggering a second national lockdown (Fig. 1a, c) . This second wave initially featured B.1 and B.1.1 sublineages, which were slightly more prevalent in the south and north of England, respectively (Fig. 2b, c) . Yet, the proportion of B.1.177 and its geographically diverse sublineages steadily increased across LTLAs from around 25% at the beginning of September to 65% at the end of October. This corresponds to a growth rate of between 8% (growth per 5.1 d; 95% confidence interval (CI) = 7-9%) and 12% (95% CI = 11-13%) greater than that of B.1 or B.1.1. The trend of B.1.177 expansion relative to B.1 persisted throughout January (Extended Data Fig. 5a ) and involved a number of monophyletic sublineages that arose in the UK, and similar patterns were observed in Denmark 17 (Extended Data Fig. 5b ). Such behaviour cannot easily be explained by international travel, which was the major factor in the initial spread of B.1. throughout Europe in summer 2020 (ref. 7 ). However, the underlying biological mechanism is unclear as the characteristic A222V spike variant is not believed to confer a growth advantage 7 .

The subsequent third wave from December 2020 to February 2021 was almost exclusively driven by Alpha/B.1.1.7, as described previously 10, 11, 18 . The rapid sweep of Alpha was due to an estimated transmissibility advantage of 1.52 compared with B.1.1 (growth per 5.1 d; 95% CI = 1.50-1.55; Fig. 2a ), assuming an unchanged generation interval distribution 19 . The growth advantage is thought to stem, at least in part, from spike mutations that facilitate ACE2 receptor binding (N501Y) 20,21 and furin cleavage (P681H) 22 . Alpha grew during a period of restrictions, which proved to be insufficient to contain its spread (Fig. 3a) . The second national lockdown from 5 November to 1 December 2020 successfully reduced the total number of cases, but this masked a lineage-specific increase (R t > 1; defined as growth per 5.1 d) in Alpha and a simultaneous decrease in other hitherto dominant lineages (R t < 1) in 78% (246/315) of LTLAs 23 (Fig. 3b, c) . This pattern of Alpha-specific growth during lockdown is supported by a model-agnostic analysis of raw case numbers and proportions of Alpha genomes (Fig. 3e) .

Three levels of regionally tiered restrictions were introduced in December 2020 (ref. 24 ) (Fig. 3a) . The areas under different tiers of restrictions visibly and quantitatively coincide with the resulting local R t values, with greater R t values in areas with lower restrictions (Fig. 3a-c) . The reopening caused a surge of cases across all tiers with R t > 1, which is also evident in selected time series (Fig. 3d ). As Alpha cases surged, more areas were placed under tier 3 restrictions, and stricter tier 4 restrictions were introduced. Nevertheless, Alpha continued to grow (R t > 1) in most areas, presumably driven by increased social interaction over Christmas (Fig. 3c) .

After the peak of 72,088 daily cases on 29 December 2020 (Fig. 1a) , a third national lockdown was announced on 4 January 2021 (Fig. 3a) . The lockdown and increasing immunity derived from infection and increasing vaccination 25 led to a sustained contraction of the epidemic to approximately 5,500 daily cases by 8 March, when restrictions began to be lifted by reopening schools (further steps of easing occurred on 12 April and 17 May). In contrast to the second national lockdown 93% (296/315) of LTLAs exhibited a contraction in both Alpha and other lineages (Fig. 3e ).

The lineage-specific rates of decline during the third national lockdown and throughout March 2021 resulted in large differences in lineage-specific incidence. Cases of Alpha contracted nationally from a peak of around 50,000 daily new cases to approximately 2,750 on 1 April 2021 (Fig. 4a ). At the same time, B.1.177-the most prevalent lineage in November 2020-fell to less than an estimated 10 cases per day. Moreover, the incidence of most other lineages present in autumn 2020 was well below 1 after April 2021, implying that the majority of them have been eliminated. The number of observed distinct PANGO lineages declined from a peak of 137 to only 22 in the first week of April 2021 (Fig. 4b) . Although this may be attributed in part to how PANGO lineages were defined, we note that the period of contraction did not replenish the genetic diversity lost due to the selective sweep by Alpha (Extended Data Fig. 6 ).

Parallel to the elimination of many formerly dominant SARS-CoV-2 lineages, a number of new variants were imported or emerged (Fig. 4a) . These include the VOCs B.1.351/Beta and P.1/Gamma, which carry the spike variant N501Y that is also found in B.1.1.7/Alpha and a similar pair of mutations (K417N/T and E484K) that were each shown to reduce the binding affinity of antibodies from vaccine-derived or convalescent sera 20, [26] [27] [28] [29] . The ability to escape from previous immunity is consistent with the epidemiology of Beta in South Africa 8 Fig. 5a , b). The proportion of these E484K-containing variants was consistently 0.3-0.4% from January to early April 2021. A transient rise, especially of the Beta and Gamma variants, was observed in May 2021 ( Fig. 5a, b ). Yet, the dynamics were largely stochastic and characterized by a series of individual and localized outbreaks, possibly curtailed by local surge testing efforts against Beta and Gamma variants (Fig. 5c ). Consistent with the transient nature of these outbreaks, the estimated growth rates of these variants were typically lower than Alpha (Fig. 2a) .

Sustained imports from international travel were a critical driving mechanism behind the observed number of non-Alpha cases. A phylogeographical analysis establishing the most parsimonious sets of monophyletic and exclusively domestic clades, which can be interpreted as individual introductions, confirmed that A.23.1 with E484K (1 clade) probably has a domestic origin as no genomes of the same clade were observed internationally (Methods, Fig. 5d and Extended Data Fig. 7) . The estimated number of introductions was lowest for B.1.1.318 (3 introductions, range = 1-6), and highest for Beta (49 introductions, range = 45-58) and Eta (30 introductions, range = 18-34). Although our data exclude genomes sampled directly from travellers, these repeated introductions show that the true rate of transmission is lower than the observed increase in the number of surveillance genomes.

The B.1.617.1/Kappa and B.1.617.2/Delta lineages, which were first detected in India in 2020, first appeared in English surveillance samples in March 2021. In contrast to other VOCs, Delta/Kappa do not contain N501Y or E484K mutations, but their L452R mutation may reduce antibody recognition 27 and P681R enhances furin cleavage 30 , similar to the P681H mutation of Alpha. The frequency of Delta, which harbours further spike mutations of unknown function, increased rapidly and reached levels of 98% (12,474/12,689) on 26 June 2021 (Fig. 5a, b) . Although initially constrained to a small number of large local clusters, such as in Bolton, in May 2021 (Fig. 5c) , Delta was detected in all LTLAs by 26 June 2021 (Fig. 1c) . The sweep of Delta occurred at a rate of around 59% (growth per 5.1 d, CI = 53-66) higher than Alpha with minor regional variation ( Table 4 ).

The rapid rise of Delta contrasts with Kappa, which grew more slowly despite being introduced at a similar time and into a similar demographic background (Figs. 2a and 5b). This is also evident in the phylogeographical analysis (based on data as of 1 May 2021). The 224 genomes of Delta derive from larger clades (23 introductions, range = 6-40; around 10 genomes for every introduction) compared with the 80 genomes of Kappa (17 introductions, range = 15-31; around 3-4 genomes per introduction) and also other variants ( Fig. 5d and Extended Data Fig. 8 ). The AY.1 lineage, derived from Delta and containing an additional K417N mutation, appeared only transiently (Fig. 5b) .

The sustained domestic growth of Delta and its international spread 31 relative to the Alpha lineage are the first evidence of a biological growth advantage. The causes appear to be a combination of increased transmissibility and immune evasion. Evidence for higher transmissibility Article includes the fast growth in younger unvaccinated age groups, reports of elevated secondary attack rates 32 and a higher viral load 33 . Furthermore, vaccine efficacy against infection by Delta is diminished, depending on the type of vaccine 34, 35 , and reinfection is more frequent 36 , both supported by experimental research demonstrating the reduced antibody neutralization of Delta by vaccine-derived and convalescent sera 37, 38 .

The higher growth rate of Delta-combined with gradual reopening and proceeding vaccination-repeated the dichotomous pattern of lineage-specific decline and growth, although now with declining Alpha (R t < 1) and growing Delta (R t > 1; Fig. 5e, f) . Overall, we estimate that the spread of more transmissible variants between August 2020 and early summer 2021 increased the average growth rate of circulating SARS-CoV-2 in England by a factor of 2.39 (95% CI = 2.25-2.42; Fig. 5g ). Thus, previously effective interventions may prove to be insufficient to contain newly emerging and more transmissible variants.

Our dense genomic surveillance analysis identified lineages that consistently grew faster than others in each local authority and, therefore, at the same time, under the same restrictions and in a comparable population. This pinpointed a series of variants with elevated transmissibility, in broad agreement with other reports 10, 11, 13, 15, 31 . However, a number of limitations exist. The growth rates of rare new variants are stochastic due to introductions and superspreading. Local outbreaks of the Beta and Gamma variants triggered asymptomatic surge testing, which may have reduced their spread. Furthermore, transmission depends both on the viral variant and the immunity of the host population, which changed from less than 20% to over 90% in the study period 39 . This will influence the growth rates of variants with immune evasion capabilities over time. The effect of immunity is currently not modelled, but may become more important in the future as SARS-CoV-2 becomes endemic. Further limitations are discussed in the Limitations section of the Methods.

The third and fourth waves in England were each caused by more transmissible variants, which outgrew restrictions that were sufficient to suppress previous variants. During the second national lockdown, Alpha grew despite falling numbers for other lineages and, similarly, Delta took hold in April and May when cases of Alpha were declining. The fact that such growth was initially masked by the falling cases of dominant lineages highlights the need for dense genomic surveillance and rapid analysis to devise optimal and timely control strategies. Such surveillance should ideally be global as, even though Delta was associated with a large wave of cases in India, its transmissibility remained unclear at the time due to a lack of systematic genomic surveillance data.

The 2.4-fold increase in growth rate during the study period as a result of new variants is also likely to have consequences for the future course of the pandemic. If this increase in growth rate was explained solely by higher transmissibility, it would raise the basic reproduction number R 0 from a value of around 2.5-3 in spring 2020 (ref. 40 ) to the range of 6-7 for Delta. This is likely to spur new waves of the epidemic in countries that have to date been able to control the epidemic despite low vaccination rates, and it may exacerbate the situation elsewhere. Although the exact herd-immunity threshold depends on contact patterns and the distribution of immunity across age groups 41, 42 , it is worth considering that Delta may increase the threshold to values around 0.85. Given current estimates of vaccine efficacy 34, 35, 43 this would require nearly 100% vaccination coverage. Even though more than 90% of adults had antibodies against SARS-CoV-2 (ref. 39 ) and close to 70% had received two doses of vaccination, England saw rising Delta variant cases in the first weeks of July 2021. It can therefore be expected that other countries with high vaccination coverage are also likely to experience rising cases when restrictions are lifted.

SARS-CoV-2 is likely to continue its evolutionary adaptation process to humans 44 . To date, variants with considerably higher transmissibility have had strongest positive selection, and swept through England during the 10 months of this investigation. However, the possibility that an increasingly immune population may now select for variants with better immune escape highlights the need for continued systematic and, ideally, global genomic surveillance.

Any methods, additional references, Nature Research reporting summaries, source data, extended data, supplementary information, acknowledgements, peer review information; details of author contributions and competing interests; and statements of data and code availability are available at https://doi.org/10.1038/s41586-021-04069-y.

as outlined above and used to fit the logarithmic incidence. The derivatives of the original basis f′(t) are used to calculate the underlying growth rates and R t values, as shown further below. The convolved spline basis f*(t) is used to fit the per capita incidence in each LTLA as (Extended Data Fig. 2b) :

This implies that fitting the incidence function for each of the m local authorities is achieved by a suitable choice of coefficients

, that is one coefficient for each spline function for each of the LTLAs. The parameters B have a univariate normal prior distribution each, which reads for LTLA i and spline j:

The s.d. of the prior regularizes the amplitude of the splines and is chosen as σ = 0.2 j for weekly splines and σ = 1 j for monthly splines. This choice was found to reduce the overall variance resulting from the high number of weekly splines, meant to capture rapid changes in growth rates, but which can lead to instabilities particularly at the end of the time series, when not all effects of changes in growth rates are observed yet. The less regularized monthly splines reflect trends on the scale of several weeks and are therefore subject to less noise.

Finally, we introduce a term accounting for periodic differences in weekly testing patterns (there are typically 30% lower specimens taken on weekends; Fig. 1a ):

where the scalar δ t δ t i i ( ) = ( − × 7) ∀ ∈N and prior distribution δ t ( ) LogNormal(0, 1) ∼ for t = 1, …, 6 and δ(0) = 1. The total incidence was fitted to the observed number of positive daily tests X by a negative binomial with a dispersion ω = 10. The overdispersion buffers against non-Poissonian uncorrelated fluctuations in the number of daily tests.

The equation above assumes that all elements of X(t) are independent, conditional on t ( ) μ .

A convenient consequence of the spline basis of log( ) = µ λ, is that the delay-adjusted daily logarithmic growth rate r(t) = λ ′ (t) of the local epidemic simplifies to:

represents the first derivative of the jth cubic spline basis function.

To express the daily growth rate as an approximate reproductive number R t , one needs to consider the distribution of the intergeneration time, which is assumed to be gamma distributed with mean 6.3 d (α = 2.29, β = 0.36) 46 . The R t value can be expressed as a Laplace transform of the intergeneration time distribution 47 . Effectively, this shortens the relative time period because the exponential dynamics put disproportionally more weight on stochastically early transmissions over late ones. For reasons of simplicity and being mindful also of the uncertainties of the intergeneration time distribution, we approximate R t values by multiplying the logarithmic growth rates with a value of τ e = 5.1 d, which was found to be a reasonable approximation to the convolution required to calculate R t values (denoted here by the lower case symbol ρ t ( ) in line with our convention for vector-variate symbols and to avoid confusion with the epidemiological growth rate r t ),

Thus, the overall growth rate scaled to an effective inter generation time of 5.1 d can be readily derived from the derivatives of the spline basis and the corresponding coefficients. The values derived from the approach are in very close agreement with those of the method of ref. 48 , but shifted according to the typical delay from infection to test (Extended Data Fig. 2b ).

The dynamics of the relative frequency P(t) of each lineage was modelled using a logistic-linear model in each LTLA, as described above. The logistic prevalence of each lineage in each LTLA is defined as t t ( ) = logit( ( )) L P . This is modelled using the piecewise linear expression L C b t t ( ) = + ⋅ , + where b may be interpreted as a lineage-specific growth advantage and C as an offset term of dimension (LTLA × lineages). Time + t is measured since introduction t 0 and is defined as

and accounts for the fact that lineages can be entirely absent prior to a stochastically distributed time period preceding their first observation. This is because, in the absence of such a term, the absence of a lineage prior to the point of observation can only be explained by a higher growth rate compared with the preceding lineages, which may not necessarily be the case. As the exact time of introduction is generally unknown, a stochastic three-week period of ∼ t t Unif(−14, 0) + 0 0 obs prior to the first observation t 0 obs was chosen.

As the inverse logit transformation projects onto the l − 1 dimensional simplex S l−1 and therefore loses one degree of freedom, B. 

The scalar parameter α α = 0.01 0 can be interpreted as a weak prior with expectation 1/n, making the model less sensitive to the introduction of single new lineages, which can otherwise exert a very strong effect. Furthermore, the array α = 1 cases 2 increases the variance to account for the fact that, especially at high sequencing coverage (genomes ≈ cases), cases and therefore genomes are likely to be correlated and overdispersed as they may derive from a single transmission event. Other choices such as α α = 1, 000 1 , which make the model converge to a standard multinomial, leave the conclusions qualitatively unchanged. This model aspect is illustrated in Extended Data Fig. 2c .

From the two definitions above it follows that the lineage-specific incidence is given by multiplying the total incidence in each LTLA µ(t) with the corresponding lineage frequency estimate P(t)for lineage j at each time point

Further corresponding lineage-specific R t values R(t) in each LTLA can be calculated from the lineage-agnostic average R t value ρ(t) and the lineage proportions P(t) as 

The model was implemented in numpyro 49, 50 and fitted using stochastic variational inference 51 . Guide functions were multivariate normal distributions for each row (corresponding to an LTLA) of B, C to preserve the correlations across lineages and time as well as for (b, c) to also model correlations between growth rates and typical introduction.

To infer VOC introduction events into the UK and corresponding clade sizes, we investigated VOC genome sequences from GISAID (https:// www.gisaid.org/) available from any country. We downloaded multiple sequence alignments of genome sequences with the release dates 17 April 2021 (for the analysis of the lineages A.23.1, B.1.1.318 On each VOC/VUI phylogeny, we inferred the minimum and maximum number of introductions of the considered SARS-CoV-2 lineage into the UK compatible with a parsimonious migration history of the ancestors of the considered samples; we also measured clade sizes for one specific example parsimonious migration history. We counted only introduction events into the UK that resulted in at least one descendant from the set of UK samples that we considered in this work for our hierarchical Bayesian model; similarly, we measured clade sizes by the number of UK samples considered here included in such clades. Multiple occurrences of identical sequences were counted as separate cases, as this helped us to identify rapid SARS-CoV-2 spread.

When using parsimony, we considered only migration histories along a phylogenetic tree that are parsimonious in terms of the number of migration events from and to the UK (in practice, we collapse all of the non-UK locations into a single one). Furthermore, as SARS-CoV-2 phylogenies present substantial numbers of polytomies, that is, phylogenetic nodes where the tree topology cannot be reconstructed due to a lack of mutation events on certain branches, we developed a tailored dynamic programming approach to efficiently integrate over all possible splits of polytomies and over all possible parsimonious migration histories. The idea of this method is somewhat similar to typical Bayesian phylogeographic inference 54 in that it enables us to at least in part integrate over phylogenetic uncertainty and uncertainty in migration history; however, it also represents a very simplified version of these analyses, more so than ref. 16 , as it considers most of the phylogenetic tree as fixed, ignores sampling times and uses parsimony instead of a likelihood-based approach. Parsimony is expected to represent a good approximation in the context of SARS-CoV-2, due to the shortness (both in time and substitutions) of the phylogenetic branches considered 55, 56 . The main advantage of our approach is that, owing to the dynamic programming implementation, it is more computationally efficient than Bayesian alternatives, as the most computationally demanding step is the inference of the maximum likelihood phylogenetic tree. This enables us to infer plausible ranges for numbers of introduction events for large datasets and to quickly update our analyses as new sequences become available. The other advantage of this approach is that it enables us to easily customize the analysis and to focus on inferred UK introductions that result in at least one UK surveillance sample, while still making use of non-surveillance UK samples to inform the inferred phylogenetic tree and migration history. Note that possible biases due to uneven sequencing rates across the world 55 apply to our approach as well as other popular phylogeographic methods. Our approach works by traversing the maximum likelihood tree starting from the terminal nodes and ending at the root (postorder traversal).

Here, we define a 'UK clade' as a maximal subtree of the total phylogeny for which all terminal nodes are from the UK, all internal nodes are inferred to be from the UK and at least one terminal node is a UK surveillance sample; the size of a UK clade is defined as the number of UK surveillance samples in it. At each node, using values already calculated for all children nodes (possibly more than two children in the case of a multifurcation), we calculate the following quantities: (1) the maximum and minimum number of possible descendant UK clades of the current node, over the space of possible parsimonious migration histories, and conditional on the current node being UK or non-UK; (2) the number of migration events compatible with a parsimonious migration history in the subtree below the current node, and conditional on the current node being UK or non-UK; (3) the size so far of the UK clade the current node is part of, conditional on it being UK; and (4) a sample of UK clade sizes for the subtree below the node. To calculate these quantities, for each internal node, and conditional on each possible node state (UK or non-UK), we consider the possible scenarios of having 0 of 1 migration events between the internal node and its children nodes (migration histories with more than 1 migration event between the node and its children are surely not parsimonious in our analysis and can be ignored).

To confirm the results of our analyses based on parsimony, we also used the new Bayesian phylogenetic approach Thorney BEAST 16 (https://beast.community/thorney_beast) for VOCs for which it was computationally feasible, that is, excluding B.1.351. For each VOC, we used in Thorney BEAST the same topology inferred with FastTree2 as for our parsimony analysis; we also used treetime 57 v.0.8.2 to estimate a timed tree and branch divergences for use in Thorney BEAST. We used a two-state (UK and non-UK) migration model 54 of migration to infer introductions into the UK but again counted, from the posterior sample trees, only UK clades with at least one UK surveillance sample. We used a Skygrid 58 tree coalescent prior with six time intervals. The comparison of parsimony and Bayesian estimates is shown in Extended Data Fig. 8d .

Data from the cross-sectional infection survey were downloaded from https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infe ctionsurveypilot/30april2021.

Comparison of ONS incidence estimates with hospitalization, case and death rates was conducted by estimating infection trajectories separately from observed cases, hospitalizations and deaths 59,60 , convolving them with estimated PCR detection curves 61 , and dividing the resulting PCR prevalence estimates by the estimated prevalence from the ONS Community Infection Survey at the midpoints of the two-week intervals over which prevalence was reported in the survey.

Maps were plotted using LTLA shapefiles (https://geoportal.statistics. gov.uk/datasets/69dc11c7386943b4ad8893c45648b1e1), sourced from the ONS, which is licensed under the Open Government Licence v.3.0.

A main limitation of the analysis is that the transmission model is deterministic, whereas the spread of variants is a stochastic process. Although the logistic growth assumption is a consistent estimator of the average transmission dynamics, individual outbreaks may deviate from these averages and therefore produce unreliable estimates.

Stochastic growth effects are accounted for only in terms of (uncorrelated) overdispersion and the offset at the time of the introduction. For these reasons, the estimated growth rates may not accurately reflect the viral transmissibility, especially at a low prevalence. It is therefore important to assess whether consistent growth patterns in multiple independent areas are observed. We note that the posterior distribution of the growth rates of rare variants tends to be biased to the baseline due to the centred prior.

In its current form, the model accounts for only a single introduction event per LTLA. Although this problem is in part alleviated by the high spatial resolution, which spreads introductions across 315 LTLAs, it is important to investigate whether sustained introductions inflate the observed growth rates, as in the case of the Delta variant or other VOCs and VUIs. This can be achieved by a more detailed phylogeographic assessment and through the assessment of monophyletic sublineages.

Furthermore, there is no explicit transmission modelled from one LTLA to another. As each introduction is therefore modelled separately, this makes the model conservative in ascertaining elevated transmission as single observed cases across different LTLAs can be explained by their introduction.

The inferred growth rates also cannot identify a particular mechanism of altered transmission. Biological mechanisms include a higher viral load, longer infectivity or greater susceptibility. Lineages could potentially differ by their intergeneration time, which would lead to nonlinear scaling. Here we did not find convincing evidence in incidence data for such effects, in contrast to previous reports 23 . However, contact-tracing data indicate that the intergeneration time may be shortening for more transmissible lineages such as Delta 33, 62 . Cases of the Beta and Gamma VOCs may have been more intensely contact traced and triggered asymptomatic surge testing in some postcode areas. This may have reduced the observed growth rates relative to other lineages.

Lineages, such as Beta, Gamma or Delta also differ in their ability to evade previous immunity. As immunity changes over time, this might lead to a differential growth advantage over time. It is therefore advisable to assess whether a growth advantage is constant over periods in which immunity changes considerably.

A further limitation underlies the nature of lineage definition and assignment. The PANGO lineage definition 5 assigns lineages to geographical clusters, which have by definition expanded, and this can induce a certain survivor bias, often followed by winner's curse. Another issue results from the fact that very recent variants may not be classified as a lineage despite having grown, which can inflate the growth rate of ancestral lineages over sublineages.

As the total incidence is modelled on the basis of the total number of positive PCR tests, it may be influenced by testing capacity; the total number of tests approximately tripled between September 2020 and March 2021. This can potentially lead to a time trend in recorded cases and therefore baseline R t values if the access to testing changed, for example, by too few tests being available tests during periods of high incidence, or changes to the eligibility to intermittently test with fewer symptoms. Generally, the observed incidence was in good agreement with representative cross-sectional estimates from the ONS 63,64 , except for a period of peak incidence from late December 2020 to January 2021 (Extended Data Fig. 1d ). Values after 8 March 2021 need to be interpreted with caution as Pillar 2 PCR testing was supplemented by lateral flow devices, which increased the number of daily tests to more than 1.5 million. Positive cases were usually confirmed by PCR and counted only once.

The modelled curves are smoothed over intervals of approximately 7 d using cubic splines, creating the possibility that later time points influence the period of investigation and cause a certain waviness of the R t value pattern. An alternative parameterization using piecewise linear basis functions per week (that is, constant R t values per week) leaves the overall conclusions and extracted parameters broadly unchanged.

This study was performed as part of surveillance for COVID-19 under the auspices of Section 251 of the National Health Service Act 2006. It therefore did not require individual patient consent or ethical approval. The COG-UK study protocol was approved by the Public Health England Research Ethics Governance Group.

Further information on research design is available in the Nature Research Reporting Summary linked to this paper.

Corresponding author(s): Moritz Gerstung Last updated by author(s): Aug 27, 2021 Reporting Summary Nature Research wishes to improve the reproducibility of the work that we publish. This form provides structure for consistency and transparency in reporting. For further information on Nature Research policies, see our Editorial Policies and the Editorial Policy Checklist.

For all statistical analyses, confirm that the following items are present in the figure legend, table legend, main text, or Methods section.

The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement A statement on whether measurements were taken from distinct samples or whether the same sample was measured repeatedly

The statistical test(s) used AND whether they are one-or two-sided Only common tests should be described solely by name; describe more complex techniques in the Methods section.

A description of all covariates tested A description of any assumptions or corrections, such as tests of normality and adjustment for multiple comparisons A full description of the statistical parameters including central tendency (e.g. means) or other basic estimates (e.g. regression coefficient) AND variation (e.g. standard deviation) or associated estimates of uncertainty (e.g. confidence intervals)

For null hypothesis testing, the test statistic (e.g. F, t, r) with confidence intervals, effect sizes, degrees of freedom and P value noted 

Policy information about availability of computer code Data collection Consensus Fasta sequences were created using the ARTIC nextflow processing pipeline and SARS-CoV-2 lineage assignments using the Pangolin software (01-04-2021 and 23-04-2021 version) and FastTree2 (2.1.11).

Code for spatio-temporal modeling of viral lineages is available at https://github.com/gerstung-lab/genomicsurveillance and as a PyPI package (genomicsurveillance). Analyses were performed in Python 3.7.1 (Packages: matplotlib (3.4.1), numpy (1.20.2), pandas (1.2.3), scikit-learn (0.19.1), scipy (1.6.2), seaborn (0.11.1), jax (0.2.8), genomicsurveillance (0.4.0), numpyro (0.4.0)). The phylogeographic analyses were performed using Thorney Beast (0.1.1) and https://github.com/NicolaDM/phylogeographySARS-CoV-2. Code for ONS infection survey analysis is available at https://github.com/jhellewell14/ons_severity_estimates. For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors and reviewers. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.

Policy information about availability of data All manuscripts must include a data availability statement. This statement should provide the following information, where applicable:

-Accession codes, unique identifiers, or web links for publicly available datasets -A list of figures that have associated raw data -A description of any restrictions on data availability PCR test data are publicly available at https://coronavirus.data.gov.uk/. SARS-CoV-2 genome data and geolocations can be obtained under controlled access from https://www.cogconsortium.uk/data/.

Phylogenetic Analysis of nCoV

Nextstrain: real-time tracking of pathogen evolution

Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Global Report Investigating Novel Coronavirus Haplotypes

Spread of a SARS-CoV-2 variant through Europe in the summer of 2020

Sixteen novel lineages of SARS-CoV-2 in South Africa

Preliminary Genomic Characterisation of an Emergent SARS-CoV-2 Lineage in the UK Defined by a Novel Set of Spike Mutations

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Tracking the International Spread of SARS-CoV-2 Lineages B.1.1.7 and B.1.351/501Y-V2

Emergence and rapid transmission of SARS-CoV-2 B.1.1.7 in the United States

Genomic Characterisation of an Emergent SARS-CoV-2 Lineage in Manaus: Preliminary Findings

Genomics and Epidemiology of the P.1 SARS-CoV-2 Lineage in Manaus

Establishment and lineage dynamics of the SARS-CoV-2 epidemic in the UK

Danish Covid-19 Genome Consortium Genomic Overview of SARS-CoV-2 in Denmark

Spatiotemporal invasion dynamics of SARS-CoV-2 lineage B.1.1.7 emergence

Roles of generation-interval distributions in shaping relative epidemic strength, speed, and control of new SARS-CoV-2 variants

Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding

SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution

Increased transmission of SARS-CoV-2 lineage B.1.1.7 (VOC 2020212/01) is not accounted for by a replicative advantage in primary airway cells or antibody escape

Lineage-specific Growth of SARS-CoV-2 B.1.1.7 During the English National Lockdown

All Tiers) (England) Regulations 2020

COVID-19) Infection Survey, Antibody and Vaccination Data for the

Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies

Complete mapping of mutations to the SARS-CoV-2 spike receptor-binding domain that escape antibody recognition

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies

The SARS-CoV-2 variants associated with infections in India, B.1.617, show enhanced spike cleavage by furin

Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at

Investigation of Novel SARS-CoV-2 Variants of Concern Technical briefing 10

Viral infection and transmission in a large well-traced outbreak caused by the Delta SARS-CoV-2 variant

Effectiveness of COVID-19 vaccines against variants of concern in Ontario

Effectiveness of Covid-19 vaccines against the B.1.617.2 (Delta) variant

Investigation of Novel SARS-CoV-2 Variants of Concern Technical briefing 19

SARS-CoV-2 B.1.617 emergence and sensitivity to vaccine-elicited antibodies

Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination

COVID-19) Infection Survey, Antibody and Vaccination Data

Reproduction Number (R) and Growth Rate (r) of the COVID-19 Epidemic in the UK: Methods of Estimation, Data Sources, Causes of Heterogeneity, and use as a Guide in Policy Formulation

A mathematical model reveals the influence of population heterogeneity on herd immunity to SARS-CoV-2

Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination

& CMMID COVID-19 Working Group The potential for vaccination-induced herd immunity against the SARS-CoV-2 B.1.1.7 variant

COVID-19, the first pandemic in the post-genomic era

The Health Protection (Coronavirus, Restrictions) (England) (No. 4) Regulations 2020. Wikipedia

Application for full data access requires a description of the planned analysis and can be initiated at coguk_DataAccess@medschl.cam.ac.uk. The data and a version of the analysis with fewer lineages can be interactively

Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: a retrospective cohort study

How generation intervals shape the relationship between growth rates and reproductive numbers

A new framework and software to estimate time-varying reproduction numbers during epidemics

Pyro: deep universal probabilistic programming

Composable effects for flexible and accelerated probabilistic programming in NumPyro

Stochastic variational inference

FastTree 2-approximately maximum-likelihood trees for large alignments

Some probabilistic and statistical problems in the analysis of DNA sequences

Bayesian phylogeography finds its roots

New routes to phylogeography: a bayesian structured coalescent approximation

Ultrafast Sample placement on Existing tRees (UShER) enables real-time phylogenetics for the SARS-CoV-2 pandemic

TreeTime: maximum-likelihood phylodynamic analysis

Improving Bayesian population dynamics inference: a coalescent-based model for multiple loci

Exploring surveillance data biases when estimating the reproduction number: with insights into subpopulation transmission of COVID-19 in England

Estimating the time-varying reproduction number of SARS-CoV-2 using national and subnational case counts

Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections

Inference of SARS-CoV-2 generation times using UK household data

results from the ONS Coronavirus Infection Survey

COVID-19) Infection Survey

Extended Data Fig. 8 | Global phylogenetic trees of B.1.617 sublineages. a, b and c. English surveillance and other (targeted and quarantine) samples are highlighted respectively orange and red. The trees of B.1.617.1 and B.1.617.2 are rooted. d. Number of UK introductions inferred by parsimony (minimum and maximum numbers) and by Thorney BEAST (95% posterior CI) for each VOC

Acknowledgements We thank E. Allara (Cambridge) and G. Whitton (Sanger) for providing outer postcodes to LTLA mappings; R. Beale for comments and J. McCrone for setting up Thorney Beast analysis; all of the contributors who submitted genome sequences to GISAID (acknowledgement tables for individual sequences are provided at GitHub; https://github. com/NicolaDM/phylogeographySARS-CoV-2); and our colleagues at EMBL-EBI, the Wellcome Sanger Institute and COG-UK for discussions and comments on this manuscript. COG-UK is supported by funding from the Medical Research Council ( A filtered, privacy conserving version of the data set is publicly available at https://covid19.sanger.ac.uk/downloads. The data and a version of the analysis with fewer lineages can be interactively explored at https://covid19.sanger.ac.uk.

Please select the one below that is the best fit for your research. If you are not sure, read the appropriate sections before making your selection.

For a reference copy of the document with all sections, see nature.com/documents/nr-reporting-summary-flat.pdf

All studies must disclose on these points even when the disclosure is negative.

The study is based on data from 281,178 viral genomes and 3,894,234 positive PCR tests collected in England during the time period from September 1, 2020 to June 30, 2021. This is an observational study based on an existing data set compiled by COG-UK, therefore no sample size calculation is applicable.Data exclusions No data was excluded in the analysis.

This is an observational study based on an existing data set compiled by COG-UK, therefore no replication is applicable.Randomization This is an observational study based on an existing data set compiled by COG-UK, therefore no randomization is applicable.Blinding This is an observational study based on an existing data set compiled by COG-UK, therefore no blinding is applicable.Reporting for specific materials, systems and methods 

Publicly available daily SARS-CoV-2 test result data from testing for the wider population outside the National Health Service (Pillar 2 newCas-esBySpecimenDate) were downloaded from https://coronavirus.data. gov.uk/ spanning the date range from 1 September 2020 to 30 June 2021 for 315 English LTLAs (downloaded on 20 July 2021). These data are mostly positive PCR tests, with about 4% of results from lateral flow tests without PCR confirmation. In this dataset, the City of London is merged with Hackney, and the Isles of Scilly are merged with Cornwall due to their small number of inhabitants, thereby reducing the number of English LTLAs from 317 to 315. Population data for each LTLA were downloaded from the Office of National Statistics (ONS; https://www. ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/populationestimatesforukenglandandwalesscotlandandnorthernireland).

In total, 281,178 tests (September 2020 to June 2021) were collected as part of random surveillance of positive tests of residents of England from four Pillar 2 Lighthouse laboratories. The samples were collected between 1 September 2020 and 26 June 2021. A random selection of samples was taken, after excluding those that were known to be taken during quarantine of recent travellers, and samples from targeted and local surge testing efforts. The available metadata made this selection imperfect, but these samples should be an approximately random selection of infections in England during this time period, and the large sample size makes our subsequent inferences robust.We amplified RNA extracts from these tests with C t < 30 using the ARTIC amplicon protocol (https://www.protocols.io/workspaces/ coguk/publications). We sequenced 384-sample pools on Illumina NovaSeq, and produced consensus fasta sequences according to the ARTIC nextflow processing pipeline (https://github.com/connor-lab/ ncov2019-artic-nf). Lineage assignments were made using Pangolin 5 , according to the latest lineage definitions at the time, except for B.1.617, which we reanalysed after the designation of sublineages B.1.617.1, B.1.617.2 and B.1.617.3. Lineage prevalence was computed from 281,178 genome sequences. The genomes were mapped to the same 315 English LTLAs as for the testing data described above. Mapping was performed from outer postcodes to LTLA, which can introduce some misassignment to neighbouring LTLAs. Furthermore, lineages in each LTLA were aggregated to counts per week for a total of 43 weeks, defined beginning on Sunday and ending on Saturday.Finally, the complete set of 328 SARS-CoV-2 PANGO lineages was collapsed into l = 71 lineages using the underlying phylogenetic tree, such that each resulting lineage constituted at least 100 genomes, unless the lineage has been designated a VOC, variant under investigation (VUI) or variant in monitoring by Public Health England 32 .

A hierarchical Bayesian model was used to fit local incidence data in a given day in each local authority and jointly estimate the relative historical prevalence and transmission parameters. In the following, t denotes time and is measured in days. We use the convention that bold lowercase symbols, such as b, indicate vectors.

Suppose that t r t t ′( ) = ( + ( )) ⋅ ( ) 0x b x describes the ordinary differential equation (ODE) for the viral dynamics for a set of l different lineages.Here r 0 (t) is a scalar time-dependent logarithmic growth rate that is thought to reflect lineage-independent transmission determinants, which changes over time in response to behaviour, non-pharmaceutical interventions (NPIs) and immunity. This reflects a scenario in which the lineages differ only in terms of the intensity of transmission, but not the intergeneration time distribution. The ODE is solved by. The term ν(t) contributes the same factor to each lineage and therefore drops from the relative proportions of lineages t ( ) = ∝eIn the given model, the lineage prevalence p(t) follows a multinomial logistic-linear trajectory. Moreover, the total incidence factorizes into t ν t ( ) = ( ) ∑ e t + µ c b, which provides a basis to separately estimate the total incidence µ(t) from Pillar 2 test data and lineage-specific prevalence p(t) from genomic surveillance data (which are taken from a varying proportion of positive tests). By using the equations above, one can subsequently calculate lineage-specific estimates by multiplying µ(t) with the respective genomic proportions p(t).

In the following text, we describe a flexible semi-parametric model of the incidence. Let µ(t) be the expected daily number of positive Pillar 2 tests and s the population size in each of 315 LTLAs. Denote λ µ t t s ( ) = log ( ) − log( ) the logarithmic daily incidence per capita at time t in each of the 315 LTLAs.Suppose f(t) is the daily number of new infections caused by the number of people infected at time t. As new cases are noticed and tested only after a delay u with distribution g, the observed number of cases f * (t) will be given by the convolutionThe time from infection to test is given by the incubation time plus the largely unknown distribution of the time from symptoms to test, which, in England, was required to take place within 5 d of symptom onset. To account for these factors, the log normal incubation time distribution from ref. 46 is scaled by the equivalent of changing the mean by 2 d. The convolution shifts cases approximately 6 d into the future and also spreads them out according to the width of g (Extended Data Fig. 2a) .To parametrize the short-and longer-term changes of the logarithmic incidence λ t ( ), we use a combination of h weekly and k − h monthly cubic basis splines f t f t f t ( ) = ( ( ), …, ( )). c. Hospitalization, case and infection fatality rates relative to ONS prevalence. Dots denote mean estimates and error bars 95% CIs.

Extended Data Fig. 2 | Genomic surveillance model of total incidence and lineage-specific frequencies. a. Cubic basis splines (top row) are convolved with the infection to test distribution (row 2 and 3) and used to fit the log incidence in a LTLA and its corresponding derivatives (growth rates; bottom row). b. Example incidence (top row), logarithmic incidence with individual convolved basis functions (dashed lines, row 2), growth rate with individual spline basis derivatives (dashed lines, row 3) and resulting (case) reproduction numbers (growth rate per 5.1d) from our approach (GenomicSurveillance) and estimates by EpiEstim 48 , shifted by 10d to approximate a case reproduction number. c. The relative frequencies of 62 different lineages are modelled using piecewise multinomial logistic regression. The linear logits are modelled to jump stochastically within 21d prior to first observation to account for the effects of new introductions. Shown are the logits of 5 selected lineages in two different LTLAs.